Metis Global Partners, LLC
Q4 2023 13F-HR Holdings
Net value change ($000)
+439,883
(21.3%)
New positions
32
Sold out positions
18
Turnover %
0.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 42,395 | 38.5% |
| PBUS | 40,541 | 9362.8% |
| AAPL | 34,523 | 27.5% |
| AMZN | 20,963 | 38.0% |
| NVDA | 16,218 | 30.9% |
| SGOL | 14,748 | 29.1% |
| BCI | 12,523 | 24.4% |
| AVGO | 12,418 | 83.9% |
| META | 11,185 | 35.4% |
| GOOGL | 8,981 | 26.6% |
Top Reduces (Value $000, Stocks/ETFs)
| AIY | -2,916 | -100.0% |
| VMWA | -2,071 | -100.0% |
| ACWI | -1,759 | -72.7% |
| BUNGELTD | -1,731 | -100.0% |
| J | -1,058 | -66.7% |
| Seagen Inc. | -706 | -100.0% |
| SEDG | -656 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -643 | -100.0% |
| COP | -573 | -9.7% |
| PCG | -564 | -31.6% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|